NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,541,629 | -0.7% | 396,421 | +9.2% | 0.00% | 0.0% |
Q2 2023 | $17,663,580 | -12.4% | 363,000 | 0.0% | 0.00% | -25.0% |
Q1 2023 | $20,153,760 | +38.2% | 363,000 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $14,581,710 | -8.3% | 363,000 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $15,907,000 | +23.6% | 363,000 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $12,865,000 | -12.9% | 363,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $14,767,000 | -75.4% | 363,000 | -43.5% | 0.00% | -66.7% |
Q4 2021 | $60,050,000 | -16.2% | 643,000 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $71,656,000 | -1.8% | 643,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $73,000,000 | +11.8% | 643,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $65,290,000 | -24.9% | 643,000 | -26.4% | 0.01% | -29.4% |
Q4 2020 | $86,980,000 | -15.7% | 874,000 | -38.8% | 0.02% | -26.1% |
Q3 2020 | $103,231,000 | +2.2% | 1,429,000 | -29.5% | 0.02% | -4.2% |
Q2 2020 | $101,016,000 | +61.4% | 2,026,000 | -3.3% | 0.02% | +33.3% |
Q1 2020 | $62,574,000 | -61.1% | 2,095,580 | -56.1% | 0.02% | -50.0% |
Q4 2019 | $160,721,000 | +2.7% | 4,770,580 | 0.0% | 0.04% | -5.3% |
Q3 2019 | $156,475,000 | +48.3% | 4,770,580 | +24.7% | 0.04% | +52.0% |
Q2 2019 | $105,547,000 | +88.5% | 3,826,949 | +40.9% | 0.02% | +78.6% |
Q1 2019 | $55,995,000 | +47.7% | 2,715,580 | 0.0% | 0.01% | +40.0% |
Q4 2018 | $37,909,000 | -50.8% | 2,715,580 | -15.5% | 0.01% | -47.4% |
Q3 2018 | $76,981,000 | +10.0% | 3,215,580 | -13.5% | 0.02% | +26.7% |
Q2 2018 | $70,000,000 | +86.5% | 3,719,470 | -8.2% | 0.02% | +87.5% |
Q1 2018 | $37,543,000 | -1.1% | 4,049,927 | -4.1% | 0.01% | 0.0% |
Q4 2017 | $37,961,000 | -30.3% | 4,222,609 | 0.0% | 0.01% | -33.3% |
Q3 2017 | $54,429,000 | +18.7% | 4,222,609 | 0.0% | 0.01% | +9.1% |
Q2 2017 | $45,858,000 | +23.4% | 4,222,609 | +0.8% | 0.01% | +22.2% |
Q1 2017 | $37,171,000 | -24.3% | 4,190,609 | 0.0% | 0.01% | -25.0% |
Q4 2016 | $49,072,000 | +7.7% | 4,190,609 | +2.2% | 0.01% | 0.0% |
Q3 2016 | $45,549,000 | -5.6% | 4,099,803 | +2.6% | 0.01% | -7.7% |
Q2 2016 | $48,233,000 | +26.7% | 3,997,803 | 0.0% | 0.01% | +18.2% |
Q1 2016 | $38,059,000 | +24.4% | 3,997,803 | +41.1% | 0.01% | +22.2% |
Q4 2015 | $30,601,000 | +61.3% | 2,833,445 | +57.8% | 0.01% | +50.0% |
Q3 2015 | $18,972,000 | – | 1,795,567 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |